Published in Clin Exp Rheumatol on March 14, 2002
Clinical development of neridronate: potential for new applications. Ther Clin Risk Manag (2013) 0.84
Successful treatment of avascular bone necrosis of the knee with neridronate: a case report. Rheumatol Int (2007) 0.81
Management of patients with complex regional pain syndrome type I. Osteoporos Int (2016) 0.76
Current options for the treatment of Paget's disease of the bone. Open Access Rheumatol (2009) 0.75
Successful neridronate therapy in pregnancy-associated osteoporosis. Clin Cases Miner Bone Metab (2017) 0.75
Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG). Osteoporos Int (2017) 0.75
Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science (1990) 3.74
Bone mineral density in patients with psoriatic arthritis. J Rheumatol (2001) 2.45
An immunoendocrinological hypothesis of HIV infection. Lancet (1994) 2.19
Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women. J Bone Miner Res (1999) 2.05
Calcitriol and calcium carbonate therapy in early chronic renal failure. Nephrol Dial Transplant (1994) 2.03
Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest (1994) 2.01
Gastroepiploic artery free graft for coronary bypass. Eur J Cardiothorac Surg (1990) 1.94
Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int (2005) 1.80
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Selectins: a family of adhesion receptors. Cell (1991) 1.72
Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer. Ann Oncol (2011) 1.58
From endothelial dysfunction to atherosclerosis. Autoimmun Rev (2010) 1.47
Bone mineralization and body composition in young patients with celiac disease. Am J Gastroenterol (1997) 1.46
Osteocalcin levels in diabetic subjects. Calcif Tissue Int (1989) 1.45
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years. Osteoporos Int (2009) 1.44
Bone mineral density in adult celiac patients and the effect of gluten-free diet from childhood. Am J Gastroenterol (1990) 1.39
Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int (2003) 1.36
Bone and mineral metabolism in adult celiac disease. Am J Gastroenterol (1988) 1.35
Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743. Proc Natl Acad Sci U S A (2000) 1.34
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res (1997) 1.31
Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int (2003) 1.29
In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloroethylnitrosoureas. Cancer Res (1987) 1.26
Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med (2000) 1.24
p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res (1997) 1.21
Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol (1991) 1.15
Abnormalities of peripheral blood T lymphocyte subsets in polymyalgia rheumatica. Clin Exp Rheumatol (1985) 1.15
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporos Int (2009) 1.13
CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. Genes Chromosomes Cancer (1999) 1.13
A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate. Br J Cancer (2010) 1.12
Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis. Exp Cell Res (1998) 1.11
Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53. Nucleic Acids Res (1994) 1.10
Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int (1986) 1.10
Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int (1986) 1.10
Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Res (1988) 1.10
The anti-inflammatory drug nimesulide rescues alpha-1-proteinase inhibitor from oxidative inactivation by phagocytosing neutrophils. Respiration (1992) 1.08
Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa. J Clin Endocrinol Metab (1979) 1.06
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer. Oncogene (2007) 1.06
Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes (1978) 1.03
PI3K/AKT/mTOR inhibitors in ovarian cancer. Curr Med Chem (2010) 1.03
High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos Int (1999) 1.02
Plasma-prolactin and cimetidine. Lancet (1977) 1.02
p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis. Oncogene (2001) 1.02
Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res (1999) 1.02
Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract (1994) 1.01
Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol. J Bone Miner Res (2000) 1.01
Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol (2000) 1.01
Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res (2003) 1.01
Cisplatinum and taxol induce different patterns of p53 phosphorylation. Neoplasia (2001) 1.00
DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status. Br J Cancer (1997) 0.99
Effect of Aplidin in acute lymphoblastic leukaemia cells. Br J Cancer (2003) 0.98
Antiangiogenic activity of aplidine, a new agent of marine origin. Br J Cancer (2004) 0.97
Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer. Gynecol Oncol (1997) 0.97
Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies. Int J Cancer (1993) 0.96
RAS/RAF/MEK inhibitors in oncology. Curr Med Chem (2012) 0.96
Dual X-ray absorptiometry for the evaluation of bone density from the proximal femur after total hip arthroplasty: analysis protocols and reproducibility. Calcif Tissue Int (1993) 0.96
Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol (2009) 0.95
The superoxide dismutase activity of desulfoferrodoxin from Desulfovibrio desulfuricans ATCC 27774. Eur J Biochem (1999) 0.95
A seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis (1990) 0.94
Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines. FASEB J (2000) 0.94
Bone assessment after total knee arthroplasty by dual-energy X-ray absorptiometry: analysis protocol and reproducibility. Calcif Tissue Int (1998) 0.94
Identification of alpha 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein. Circ Res (1989) 0.94
Bisphosphonate therapy of reflex sympathetic dystrophy syndrome. Ann Rheum Dis (1997) 0.94
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Miner Res (1994) 0.94
Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes (Lond) (2006) 0.93
In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinoma. Cancer Chemother Pharmacol (1986) 0.93
P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line. Cancer Res (2001) 0.93
Differential distribution of antitumor agents in primary and secondary tumors. Cancer Treat Rep (1977) 0.93
Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. J Bone Miner Res (2001) 0.93
Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart (2004) 0.93
DeltaNp63 expression is associated with poor survival in ovarian cancer. Ann Oncol (2007) 0.92
Periprosthetic bone density around fully hydroxyapatite coated femoral stem. Clin Orthop Relat Res (1997) 0.92
Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage. Clin Cancer Res (1999) 0.92
Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. Curr Med Res Opin (2007) 0.91
Tilted implants in the immediate loading rehabilitation of the maxilla: a systematic review. J Dent Res (2012) 0.91
Gitelman disease associated with growth hormone deficiency, disturbances in vasopressin secretion and empty sella: a new hereditary renal tubular-pituitary syndrome? Pediatr Res (1999) 0.91
Metoclopramide increases plasma aldosterone concentration in man. J Clin Endocrinol Metab (1977) 0.91
p53 regulates the minimal promoter of the human topoisomerase IIalpha gene. Nucleic Acids Res (1996) 0.91
Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib. Int J Clin Pract (2007) 0.91
High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest (2006) 0.91
Glucocorticoids and Th-1, Th-2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDS. Clin Exp Rheumatol (1997) 0.90
Within-patient variability of hormone and cytokine concentrations in heart failure. Pharmacol Res (1998) 0.90
Selective impairment of pancreatic A cell suppression by glucose during acute alloxan-induced insulinopenia: in vitro study on isolated perfused rat pancreas. Endocrinology (1986) 0.90
Regional migratory osteoporosis: a pathogenetic hypothesis based on three cases and a review of the literature. Clin Rheumatol (2002) 0.90
Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53. Int J Cancer (1997) 0.89
Cardiomyopathy and multicore myopathy with accumulation of intermediate filaments. Eur J Pediatr (1990) 0.89
Prevalence of left-sided obstructive lesions in patients with atrioventricular canal without Down's syndrome. J Thorac Cardiovasc Surg (1986) 0.89
Trail activity in human ovarian cancer cells: potentiation of the action of cytotoxic drugs. Eur J Cancer (2002) 0.89
Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos Int (2003) 0.89
Cardiac catheterization through the internal jugular vein in pediatric patients. An alternative to the usual femoral vein access. Chest (1992) 0.88
Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates. J Heart Lung Transplant (1994) 0.88
Glucocorticoids and interferon-alpha in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1996) 0.88
Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Horm Res (2000) 0.88
Effects of tramadol on synovial fluid concentrations of substance P and interleukin-6 in patients with knee osteoarthritis: comparison with paracetamol. Int Immunopharmacol (2003) 0.88
Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin. Br J Cancer (1995) 0.88
Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice. Cancer Treat Rep (1978) 0.88
Computed radiographic absorptiometry and morphometry in the assessment of postmenopausal bone loss. Osteoporos Int (1996) 0.88
Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1992) 0.87